Yes-Associated Protein 1 (YAP1) Antibody
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
YAP1 Antibody is a Rabbit Polyclonal Antibody against YAP1.
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Yes-Associated Protein 1 (YAP1) |
| Host | Rabbit |
| Reactivity | Human, Mouse, Rat |
| Recommended Dilution | IHC-P: 1/50 - 1/100, IF/ICC: 1/50 - 1/200. Not tested in IHC-F. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Purified by affinity chromatography. |
| Size 1 | 60 µl |
| Size 2 | 120 µl |
| Size 3 | 200 µl |
| Form | Liquid |
| Tested Applications | IHC, IF/ICC |
| Buffer | PBS, pH 7.3, containing 0.02% sodium azide, 50% glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P46937 |
| Gene ID | 10413 |
| NCBI Accession | NP_001123617.1 |
| Background | Antibody anti-YAP1 |
| Status | RUO |
| Note | Concentration: 1 mg/ml - |
Descripción
Related Products
Human YAP1 (Transcriptional coactivator YAP1) ELISA Kit
Ver Producto
YAP1 antibody
This gene encodes a downstream nuclear effector of the Hippo signaling pathway which is involved in development, growth, repair, and homeostasis. This gene is known to play a role in the development and progression of multiple cancers as a transcriptional regulator of this signaling pathway and may function as a potential target for cancer treatment. Alternative splicing results in multiple transcript variants encoding different isoforms.
Ver ProductoYAP1 antibody
This gene encodes a downstream nuclear effector of the Hippo signaling pathway which is involved in development, growth, repair, and homeostasis. This gene is known to play a role in the development and progression of multiple cancers as a transcriptional regulator of this signaling pathway and may function as a potential target for cancer treatment. Alternative splicing results in multiple transcript variants encoding different isoforms.
Ver Producto